DC

Dheeraj Chaitanya Gorremuchu

Active Director Managing Director DIN 10572608
DIN 10572608 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Dheeraj Chaitanya Gorremuchu

Data last updated:

Dheeraj Chaitanya Gorremuchu is a Managing Director at Medavenew Healthcare Private Limited (since 2024).

DIN 10572608
Primary Designation Managing Director
First Appointment 01 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medavenew Healthcare Private Limited U86201AP2024PTC114388
Managing Director01 Apr 20242024Active

Board colleagues of Dheeraj Chaitanya Gorremuchu

Directorship timeline

Open interactive timeline →
Medavenew Healthcare Private Limited
Premium access

Shareholding and investment profile for Dheeraj Chaitanya Gorremuchu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dheeraj Chaitanya Gorremuchu

Dheeraj Chaitanya Gorremuchu currently holds 1 directorship: Medavenew Healthcare Private Limited (Managing Director, since 01 Apr 2024).

Dheeraj Chaitanya Gorremuchu was first appointed on 01 Apr 2024 as Managing Director at Medavenew Healthcare Private Limited.

The current boards of Dheeraj Chaitanya Gorremuchu's companies include Krishna Chander Pudi Ram (Medavenew Healthcare Private Limited), Rahamath Ali Baig Mughal (Medavenew Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available